NCT05595915View on ClinicalTrials.gov

COMP-4 Supplementation and Brachial Artery FMD

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2026

Conditions
AgingEndothelial DysfunctionSenescence
Interventions
DIETARY_SUPPLEMENT

COMP-4

COMP-4 is a novel compound that consists of ginger extract, L-citrulline, and the herbal components Paullinia cupana and muira puama.

Trial Locations (1)

90034

UCLA, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER